Scarica l'app Stockscreener
18.38
2.91%
0.52
Dopo l'orario di chiusura:
18.26
-0.12
-0.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ERAS Giù?
Forum
Previsione
Erasca Inc Borsa (ERAS) Ultime notizie
Does Legal Scrutiny And Leadership Change Reshape The Bull Case For Erasca’s ERAS-0015 Program (ERAS)? - simplywall.st
ERAS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
ERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - Stocktwits
Erasca (ERAS) insiders report 10.4% and 5.6% ownership stakes - Stock Titan
ERAS Maintained by B of A Securities -- Price Target Raised to $20 - GuruFocus
Bank of America Issues Positive Forecast for Erasca (NASDAQ:ERAS) Stock Price - MarketBeat
Erasca, Inc. Stock 12‑Month Price Target Raised to $23, Implies 29% Upside - TradingView
Attention Long-Term Shareholders of ARS Pharmaceuticals, - globenewswire.com
HC Wainwright Has Negative Estimate for Erasca Q3 Earnings - MarketBeat
BofA Adjusts Price Target on Erasca to $20 From $18 - marketscreener.com
Erasca, Inc. (NASDAQ:ERAS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Guggenheim raises Erasca stock price target to $21 on pipeline progress - Investing.com South Africa
Erasca Awards 1.3 Million Stock Options to New President of R&D - Kalkine Media
Erasca, Inc. Stock 12‑Month Price Target Raised to $22.82, Implies 25% Upside - TradingView
Erasca, Inc. Stock 12‑Month Price Target Raised to $22.73, Implies 24% Upside - TradingView
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers - The Manila Times
Erasca (NASDAQ:ERAS) Given New $22.00 Price Target at HC Wainwright - MarketBeat
H.C. Wainwright raises Erasca stock price target on trial progress By Investing.com - Investing.com South Africa
H.C. Wainwright raises Erasca stock price target on trial progress - Investing.com
ERAS Maintained by HC Wainwright & Co. -- Price Target Raised to $22 - GuruFocus
Bank of America Corp DE Raises Position in Erasca, Inc. $ERAS - MarketBeat
Erasca (NASDAQ:ERAS) Announces Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Erasca Q2 EPS of $(0.14) misses $(0.11) estimate on R&D spend - scanx.trade
Earnings Flash (ERAS) Erasca Posts Q2 Loss $0.14 per Share, vs. FactSet Est of $0.11 Loss - marketscreener.com
Erasca, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
ERAS: ERAS-0015 delivers strong efficacy and safety in RAS-mutant cancers, advancing toward pivotal trials - TradingView
Erasca Reports Second Quarter 2026 Business Updates and Financial Results - The Manila Times
Erasca, Inc. 2Q 2026: Net income $(44.1M), EPS $(0.14) — 10-Q Summary - TradingView
Erasca (ERAS) boosts cash by $836M while advancing RAS oncology pipeline - Stock Titan
Erasca, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Important Notice to Long-Term Shareholders of Erasca, Inc. - GlobeNewswire
ERAS DEADLINEFINAL REMINDER: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
812,876 Shares in Erasca, Inc. $ERAS Acquired by Assenagon Asset Management S.A. - MarketBeat
Erasca appoints Charles Fuchs as R&D president By Investing.com - Investing.com India
Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Press Release: Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Moomoo
Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Eras - GuruFocus
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - 巴士的報
Erasca appoints Charles Fuchs as R&D president - Investing.com
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Reed Kathrein at Hagens Berman Sobol Shapiro LLP By Application Deadline - PR Newswire
Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D - The Manila Times
Erasca, Inc. Announces Appointment of Charles S. Fuchs as President of Research and Development, Effective on August 10, 2026 - marketscreener.com
California State Teachers Retirement System Grows Position in Erasca, Inc. $ERAS - MarketBeat
Kaplan Fox Alerts Erasca, Inc. (NASDAQ: ERAS) Investors to Seek L - The National Law Review
ERAS DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Erasca, Inc. Investors to Participate in the Class Action Lawsuit Today - ACCESS Newswire
ERAS DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts - The National Law Review
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Erasca 48 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc.ERAS - ACCESS Newswire
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure ... - Caledonian Record
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, - globenewswire.com
ERAS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - ACCESS Newswire
The Manufacturers Life Insurance Company Acquires 161,845 Shares of Erasca, Inc. $ERAS - MarketBeat
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ERAS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Erasca 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc.ERAS - Business Wire
ERASCA LEAD PLAINTIFF DEADLINE AUGUST 10th: Bragar Eagel & - GlobeNewswire
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):